Israeli biopharmaceutical agency Mileutis stated on Tuesday outcomes from a scientific trial confirmed that its non-antibiotic substitute to deal with infections in cows boosted milk high quality in dairy cows.
Mileutis performed a trial in seven Israeli dairy farms together with Strauss Health, which is partly owned by France’s Danone. The trial of greater than 500 dairy cows was carried out at farms that present milk to 2 of Israel’s largest dairy suppliers – Strauss and Tnuva, owned by China’s Bright Food and Dairy Co.
The firm, based in 2004, has developed a remedy to deal with udder irritation in cows with out antibiotics that it stated would scale back well being dangers to people.
It stated that milk derived from cows handled with its non-antibiotic, non-hormonal remedy confirmed a 7.2% improve in protein content material, a 4% rise in fats content material and a 8.6% acquire in milk yield per cow over 305 days.
“Beyond an increase in the yield and welfare of cows, the improved profitability of dairy farmers can impact milk prices and benefit the broader consumer market while meeting growing global demand,” stated Mileutis CEO David Javier Iscovich.
“Consumers can anticipate a future where they will enjoy better milk, produced by healthier cows, and with superior nutritional values.”
Source: www.anews.com.tr
